Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Identify bond funds that offer tax-exempt income in retirement and how to incorporate them for tax-efficient withdrawals.
23,934 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
XRP recently pulled back sharply, turning the focus from hype to fundamentals. In this guide, we explore what drives ...
Pi Network’s PI tumbles to a fresh all-time low as a 130 million token unlock looms, signaling potential further down...
Amazon trimmed 16,000 jobs in early 2026, even as CEO Jeff Bezos warned AI could create a labor shortage. The clash b...
A top tech analyst argues memory chips are the AI backbone, with a widening 15-to-1 demand-to-supply gap shaping mark...
Korean chip equities are wavering after a blistering AI-driven rally, with the KOSPI retreating and memory peers weig...
Apple sidesteps the AI capex race, prioritizing software and on-device AI. Analysts see a bigger iPhone upgrade cycle...
The KORU 3X South Korea Bull ETF jumps on a memory stock rally after SK Hynix confirms mass production of HBM4 for NV...
UBS flags a return of leadership for AI stocks as earnings season kicks into high gear, with this wall street ‘theme-...
American manufacturers are racing to deploy fully automated, lights-out factories in North America as robotics and AI...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...